[{"id":"79778409-4ae2-4e9c-aeca-2b7195069e98","acronym":"","url":"https://clinicaltrials.gov/study/NCT01995708","created_at":"2021-02-01T11:52:42.148Z","updated_at":"2024-07-02T16:35:19.997Z","phase":"Phase 1","brief_title":"CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation","source_id_and_acronym":"NCT01995708","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" WT1 • MAGEA3 • MAGEC1","pipe":"","alterations":" ","tags":["WT1 • MAGEA3 • MAGEC1"],"overall_status":"Completed","enrollment":" Enrollment 28","initiation":"Initiation: 01/31/2014","start_date":" 01/31/2014","primary_txt":" Primary completion: 06/20/2022","primary_completion_date":" 06/20/2022","study_txt":" Completion: 06/20/2022","study_completion_date":" 06/20/2022","last_update_posted":"2024-02-09"}]